Comment on

• Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

  Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Sanders GD, et al. N Engl J Med. 2005 Feb 10;352(6):570-85. doi: 10.1056/NEJMsa042657. N Engl J Med. 2005. PMID: 15703422